In the present study, NOX/Akt/PKC pathway inhibition, which led to an increase in Bcl-XL and a decrease in Bax and caspase-3, indicates that it is involved in neuronal apoptotic mechanisms and, therefore, has potential for future stroke therapy. This evidence concerns the gene BAX and stroke disorder.